Cardinal Health (CAH) Competitors $152.58 +3.29 (+2.20%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSICShould you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector. Cardinal Health vs. Its Competitors DexCom Hologic Merit Medical Systems AMN Healthcare Services Cencora Elevance Health Haemonetics Integer McKesson Henry Schein Cardinal Health (NYSE:CAH) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends. Do institutionals & insiders hold more shares of CAH or DXCM? 87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor CAH or DXCM? In the previous week, Cardinal Health had 6 more articles in the media than DexCom. MarketBeat recorded 40 mentions for Cardinal Health and 34 mentions for DexCom. Cardinal Health's average media sentiment score of 1.22 beat DexCom's score of 0.98 indicating that Cardinal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 30 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive DexCom 18 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is CAH or DXCM more profitable? DexCom has a net margin of 13.29% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.41% beat Cardinal Health's return on equity.Company Net Margins Return on Equity Return on Assets Cardinal Health0.70% -74.45% 4.14% DexCom 13.29%30.41%10.08% Which has higher valuation & earnings, CAH or DXCM? Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardinal Health$222.58B0.16$1.56B$6.4523.64DexCom$4.03B7.44$576.20M$1.4453.13 Which has more volatility and risk, CAH or DXCM? Cardinal Health has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Do analysts rate CAH or DXCM? Cardinal Health currently has a consensus price target of $165.93, suggesting a potential upside of 8.85%. DexCom has a consensus price target of $99.89, suggesting a potential upside of 30.56%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Cardinal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.79DexCom 0 Sell rating(s) 5 Hold rating(s) 14 Buy rating(s) 3 Strong Buy rating(s) 2.91 SummaryDexCom beats Cardinal Health on 12 of the 17 factors compared between the two stocks. Get Cardinal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAH vs. The Competition Export to ExcelMetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$36.39B$15.39B$5.83B$21.62BDividend Yield1.35%1.52%5.25%3.51%P/E Ratio23.6317.7475.8029.82Price / Sales0.162.24533.4051.17Price / Cash12.9413.3837.4224.46Price / Book-13.813.4411.874.60Net Income$1.56B$472.94M$3.29B$999.91M7 Day Performance2.05%-1.08%1.97%1.48%1 Month Performance-3.56%-0.18%8.90%6.90%1 Year Performance34.54%9.04%66.28%17.38% Cardinal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAHCardinal Health4.983 of 5 stars$152.58+2.2%$165.93+8.8%+30.7%$36.43B$222.58B23.6557,700Positive NewsShort Interest ↑DXCMDexCom4.9547 of 5 stars$77.99-3.1%$99.89+28.1%+10.9%$30.58B$4.03B54.1610,300News CoverageAnalyst DowngradeInsider TradeHOLXHologic4.9069 of 5 stars$66.54-0.3%$78.00+17.2%-20.1%$14.80B$4.03B27.617,063News CoveragePositive NewsMMSIMerit Medical Systems4.6616 of 5 stars$92.25-0.8%$107.00+16.0%-8.2%$5.46B$1.36B46.837,400Positive NewsAMNAMN Healthcare Services4.4781 of 5 stars$20.97+0.6%$28.25+34.7%-56.7%$803.61M$2.98B-2.702,968Trending NewsAnalyst ForecastShort Interest ↓Analyst RevisionCORCencora4.7626 of 5 stars$297.64+1.8%$311.25+4.6%+24.8%$57.71B$293.96B30.6246,000News CoveragePositive NewsELVElevance Health4.8868 of 5 stars$308.03-1.8%$411.06+33.4%-43.6%$69.36B$177.01B13.11104,200Gap UpHAEHaemonetics4.9055 of 5 stars$54.02-0.7%$85.18+57.7%-27.5%$2.60B$1.36B16.523,023News CoveragePositive NewsShort Interest ↑Analyst RevisionITGRInteger3.8495 of 5 stars$106.01-0.9%$140.25+32.3%-16.8%$3.71B$1.72B46.7011,000Positive NewsMCKMcKesson4.5089 of 5 stars$696.53+1.3%$725.10+4.1%+39.6%$86.63B$359.05B27.7745,000News CoveragePositive NewsHSICHenry Schein3.7069 of 5 stars$67.74-2.4%$76.67+13.2%-0.2%$8.21B$12.67B21.8525,000Positive News Related Companies and Tools Related Companies DexCom Competitors Hologic Competitors Merit Medical Systems Competitors AMN Healthcare Services Competitors Cencora Competitors Elevance Health Competitors Haemonetics Competitors Integer Competitors McKesson Competitors Henry Schein Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CAH) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CAH Stock Alerts